Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors
TORONTO, ON / ACCESSWIRE / May 4, 2021 / Ripple Therapeutics Corporation ("Ripple") a clinical stage, ophthalmology-focused developer of novel...
Day: May 4, 2021
Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics
New clinics represent the first phase of Novamind's national expansion strategy TORONTO, ON / ACCESSWIRE / May 4, 2021 /...
Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol
--R&D Program Developing 100% Optimi-Owned Psychedelic Capsule for Human Clinical Trial Dosing StudyVANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE)...
Vaccine Science and Policy Experts Call for Transformation of Vaccine R&D Enterprise
WASHINGTON, May 04, 2021 (GLOBE NEWSWIRE) -- As the world continues to grapple with the significant impact of the COVID-19...
Shineco, Inc. Proposes to Acquire 51% Equity Interests in Mayah Biological Holdings Limited
BEIJING, May 04, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of...
Icario Partners with CVC to Fuel Next Phase of Growth
Global private equity firm brings world-class resources and support to Icario’s current and future customersMINNEAPOLIS, May 04, 2021 (GLOBE NEWSWIRE)...
Cannabix Technologies Receives Notice of Allowance for Detection of Molecules – FAIMS U.S. Patent
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
Editas Medicine to Present Preclinical Data Demonstrating Progress in Development of Gene Editing Medicines for the Treatment of Genetic Ocular Diseases at the American Society of Gene and Cell Therapy Annual Meeting
CAMBRIDGE, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced...
Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report
Company ranked first in Customer Loyalty and among top-two global CROs for Service Provider Leadership, Familiarity, Use and Preference; achieves...
Resonant to Host One-On-One Meetings at the Oppenheimer 6th Annual Emerging Growth Conference on May 11th and 12th
AUSTIN, Texas, May 04, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions...
Xtant Medical to Issue First Quarter 2021 Financial Results on May 11, 2021
BELGRADE, Mont., May 04, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company...
Yield10 Bioscience to Announce First Quarter 2021 Financial Results and Host a Conference Call on Tuesday, May 11, 2021
WOBURN, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the...
American Cannabis Company, Inc. Receives Approval from Colorado’s Marijuana Enforcement Division (MED) and the City of Colorado Springs to Acquire, Own, and Operate Naturaleaf™ in Southern Colorado
DENVER, CO, May 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”)...
Galecto Reports First Quarter Financial Results and Provides a Corporate Update
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development...
Revolo Biotherapeutics Announces Positive Data from Additional Phase 1 Clinical Trial of ‘1104, its Peptide Drug for Allergic Disease
‘1104 was safe and well-tolerated without serious adverse eventsNEW ORLEANS and LONDON, May 04, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics...
Todos Medical Receives FDA Certificate of Free Sale for New 5-Day Tollovid Dosing Regimen
Company sees this new dosing regimen of 60 pills over 5 days as optimal for Tollovid, the Company’s 3CL protease...
Myovant Sciences to Host Fourth Fiscal Quarter and Fiscal Year 2020 Earnings Conference Call at 8:30 a.m. Eastern Time on May 11, 2021
BASEL, Switzerland, May 04, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women...
Better Choice Company to Host First Quarter 2021 Earnings Call on May 13th at 8:30 a.m. ET
NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”), an animal health and wellness...
EDAP TMS SA to Announce First Quarter 2021 Financial Results on May 11, 2021
Company to host conference call and webcast on Wednesday, May 12 at 8:30 am EDT LYON, France, May 4, 2021...
eFFECTOR and Quantitative Biosciences Institute (QBI) at UCSF Receive $5.0 Million from DARPA to Evaluate Zotatifin in COVID-19
Funding will support planned Phase 1b anti-viral study in patients with mild to moderate COVID-19 infectionsSAN DIEGO, May 04, 2021...